StockNews.com began coverage on shares of Accelerate Diagnostics (NASDAQ:AXDX – Free Report) in a research report report published on Tuesday morning. The firm issued a hold rating on the medical research company’s stock.
Accelerate Diagnostics Price Performance
Shares of NASDAQ:AXDX opened at $1.73 on Tuesday. The company has a market capitalization of $38.15 million, a price-to-earnings ratio of -0.43 and a beta of 0.57. The firm’s 50 day simple moving average is $1.45 and its 200 day simple moving average is $1.18. Accelerate Diagnostics has a fifty-two week low of $0.73 and a fifty-two week high of $7.00.
Accelerate Diagnostics (NASDAQ:AXDX – Get Free Report) last posted its earnings results on Thursday, August 8th. The medical research company reported ($0.50) earnings per share for the quarter, topping the consensus estimate of ($0.55) by $0.05. The firm had revenue of $2.99 million during the quarter, compared to analyst estimates of $3.00 million. Equities research analysts expect that Accelerate Diagnostics will post -2.14 earnings per share for the current year.
Institutional Inflows and Outflows
About Accelerate Diagnostics
Accelerate Diagnostics, Inc, an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms.
Further Reading
- Five stocks we like better than Accelerate Diagnostics
- What is the Euro STOXX 50 Index?
- Does GTA VI Make Take-Two Interactive Stock an Irresistible Buy?
- What Are the FAANG Stocks and Are They Good Investments?
- Why HPE’s Dip Is a Prime Opportunity for Blue-Chip AI Investors
- Compound Interest and Why It Matters When Investing
- Why Analysts See Big Upside for Occidental Petroleum Despite Lows
Receive News & Ratings for Accelerate Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Accelerate Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.